Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495115 · ClinicalTrials.gov registry record · NA
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 460
- Enrollment target
NCT03495115 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 460 participants.
The verdict
NCT03495115, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
Study Summary
This study is looking at a breast cancer screening technique, restriction spectrum imaging (RSI), as a possible alternative to the breast Magnetic Resonance Imaging (MRI) used by most healthcare professionals. The technique involved in this study is: -Restriction Spectrum Imaging (RSI)
Interventions
- DEVICE MRI
- DEVICE RSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2023-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03495115
The ClinicalTrials.gov registry entry for NCT03495115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT03495115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03495115 about?
NCT03495115 is a clinical study titled "Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening". This study is looking at a breast cancer screening technique, restriction spectrum imaging (RSI), as a possible alternative to the breast Magnetic Resonance Imaging (MRI) used by most healthcare professionals. The technique involved in this study is: -Restriction Spectrum Imaging (RSI)
What is the current status of trial NCT03495115?
This trial is currently completed. It is a NA study. The enrollment target is 460 participants. The study started on 2018-04-18. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT03495115?
The interventions under investigation include: MRI (DEVICE), RSI (DEVICE).
Who is sponsoring clinical trial NCT03495115?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.